270
Participants
Start Date
October 1, 2025
Primary Completion Date
April 30, 2028
Study Completion Date
July 30, 2028
reSTART Objective Adherence Self-Monitoring and Postive Affect mHealth Intervention
The reSTART intervention integrates a mobile health application, a urine tenofovir point-of-care self-test, and adherence feedback with motivational messages to increase HIV medication intake, reduce stimulant use, and improve HIV virologic suppression.
urine tenofovir point-of-care self-test
urine tenofovir point-of-care self-test
University of California, San Francisco, San Francisco
Florida International University
OTHER
San Diego State University
OTHER
National Institute on Drug Abuse (NIDA)
NIH
University of California, San Francisco
OTHER